<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Thu, 07 Aug 2008 21:26:31 BST</pubDate>


	<title>CiteULike: Author Loetscher</title>
	<description>CiteULike: Author Loetscher</description>


	<link>http://www.citeulike.org/author/Loetscher</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/HugoMarcelo/article/1676103"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/RamuAnandakrishnan/article/2978141"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/brembs/article/2307582"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/1183715"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jjray/article/1590153"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/Fritz/article/714137"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/rhem1224/article/705818"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/tkershaw/article/393499"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/tkershaw/article/393498"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/yedmonds/article/234945"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/yedmonds/article/234925"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/HugoMarcelo/article/1676103">
    <title>Chemokines: multiple levels of leukocyte migration control*</title>
    <link>http://www.citeulike.org/user/HugoMarcelo/article/1676103</link>
    <description>&lt;i&gt;Trends in Immunology, Vol. 25, No. 2. (February 2004), pp. 75-84.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;The surge in interest in chemokines is explained by the recognition that numerous aspects of immunity are intimately related to leukocyte traffic. Chemokines are leukocyte attractants but also contribute to immune processes that do not directly involve leukocyte migration. Recent progress is most evident in the areas of lymphocyte development, immune response initiation and immune pathology. Important observations have also been reported on chemokine-receptor interactions, signal transduction and cellular responses. New insights into the role of chemokines in leukocyte attraction and relocation will be discussed, with emphasis on the distinct levels of leukocyte migration control that ultimately determine the performance of our immune defense system.</description>
    <dc:title>Chemokines: multiple levels of leukocyte migration control*</dc:title>

    <dc:creator>Bernhard Moser</dc:creator>
    <dc:creator>Marlene Wolf</dc:creator>
    <dc:creator>Alfred Walz</dc:creator>
    <dc:creator>Pius Loetscher</dc:creator>
    <dc:identifier>doi:10.1016/j.it.2003.12.005</dc:identifier>
    <dc:source>Trends in Immunology, Vol. 25, No. 2. (February 2004), pp. 75-84.</dc:source>
    <dc:date>2007-09-19T14:01:44-00:00</dc:date>
    <prism:publicationYear>2004</prism:publicationYear>
    <prism:publicationName>Trends in Immunology</prism:publicationName>
    <prism:volume>25</prism:volume>
    <prism:number>2</prism:number>
    <prism:startingPage>75</prism:startingPage>
    <prism:endingPage>84</prism:endingPage>
    <prism:category>chemokine</prism:category>
    <prism:category>review</prism:category>
    <prism:category>tania_tb_paper</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/RamuAnandakrishnan/article/2978141">
    <title>Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from Plasmodium falciparum</title>
    <link>http://www.citeulike.org/user/RamuAnandakrishnan/article/2978141</link>
    <description>&lt;i&gt;Nat Struct Mol Biol, Vol. 6, No. 1. (January 1999), pp. 32-37.&lt;/i&gt;</description>
    <dc:title>Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from Plasmodium falciparum</dc:title>

    <dc:creator>Nina Bernstein</dc:creator>
    <dc:creator>Maia Cherney</dc:creator>
    <dc:creator>Hansruedi Loetscher</dc:creator>
    <dc:creator>Robert Ridley</dc:creator>
    <dc:creator>Michael James</dc:creator>
    <dc:identifier>doi:10.1038/4905</dc:identifier>
    <dc:source>Nat Struct Mol Biol, Vol. 6, No. 1. (January 1999), pp. 32-37.</dc:source>
    <dc:date>2008-07-09T17:42:31-00:00</dc:date>
    <prism:publicationYear>1999</prism:publicationYear>
    <prism:publicationName>Nat Struct Mol Biol</prism:publicationName>
    <prism:volume>6</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>32</prism:startingPage>
    <prism:endingPage>37</prism:endingPage>
    <prism:category>pka</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/brembs/article/2307582">
    <title>Head turns bias the brain's internal random generator</title>
    <link>http://www.citeulike.org/user/brembs/article/2307582</link>
    <description>&lt;i&gt;Current Biology, Vol. 18, No. 2. (22 January 2008), pp. R60-R62.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Summary Numerical and spatial cognition rely on common functional circuits in the parietal lobes of the brain [1]. While previous work has established that the mere perception of numbers can bias a subject's attention in space [2], the method of random digit generation has only recently been introduced to a rapidly growing literature exploring asymmetries in number space [3]. Here we show that human subjects' attempts to generate numbers `at random' are systematically influenced by lateral head turns, which are known to reallocate spatial attention in the outside world. Specifically, while facing left, subjects produced relatively small numbers, whereas while facing right they tended to produce larger numbers. These results support current concepts of parietal cortex as mediating the interplay between spatial attention and abstract thought [4].</description>
    <dc:title>Head turns bias the brain's internal random generator</dc:title>

    <dc:creator>Tobias Loetscher</dc:creator>
    <dc:creator>Urs Schwarz</dc:creator>
    <dc:creator>Michele Schubiger</dc:creator>
    <dc:creator>Peter Brugger</dc:creator>
    <dc:identifier>doi:10.1016/j.cub.2007.11.015</dc:identifier>
    <dc:source>Current Biology, Vol. 18, No. 2. (22 January 2008), pp. R60-R62.</dc:source>
    <dc:date>2008-01-30T14:47:28-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>Current Biology</prism:publicationName>
    <prism:volume>18</prism:volume>
    <prism:number>2</prism:number>
    <prism:startingPage>R60</prism:startingPage>
    <prism:endingPage>R62</prism:endingPage>
    <prism:category>numbers</prism:category>
    <prism:category>random</prism:category>
    <prism:category>spontaneous</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/1183715">
    <title>The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db Mice</title>
    <link>http://www.citeulike.org/user/jyuh/article/1183715</link>
    <description>&lt;i&gt;American Journal of Pathology, Vol. 170, No. 4. (1 April 2007), pp. 1267-1276.&lt;/i&gt;</description>
    <dc:title>The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db Mice</dc:title>

    <dc:creator>Ninichuk</dc:creator>
    <dc:creator>Volha</dc:creator>
    <dc:creator>Khandoga</dc:creator>
    <dc:creator>G Alexander</dc:creator>
    <dc:creator>Segerer</dc:creator>
    <dc:creator>Stephan</dc:creator>
    <dc:creator>Loetscher</dc:creator>
    <dc:creator>Pius</dc:creator>
    <dc:creator>Schlapbach</dc:creator>
    <dc:creator>Achim</dc:creator>
    <dc:creator>Revesz</dc:creator>
    <dc:creator>Laszlo</dc:creator>
    <dc:creator>Feifel</dc:creator>
    <dc:creator>Roland</dc:creator>
    <dc:creator>Khandoga</dc:creator>
    <dc:creator>Andrej</dc:creator>
    <dc:creator>Krombach</dc:creator>
    <dc:creator>Fritz</dc:creator>
    <dc:creator>Nelson</dc:creator>
    <dc:creator>J Peter</dc:creator>
    <dc:creator>Schlondorff</dc:creator>
    <dc:creator>Detlef</dc:creator>
    <dc:creator>Anders</dc:creator>
    <dc:creator>Hans-Joachim</dc:creator>
    <dc:identifier>doi:10.2353/ajpath.2007.060937</dc:identifier>
    <dc:source>American Journal of Pathology, Vol. 170, No. 4. (1 April 2007), pp. 1267-1276.</dc:source>
    <dc:date>2007-03-24T18:07:16-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>American Journal of Pathology</prism:publicationName>
    <prism:issn>0002-9440</prism:issn>
    <prism:volume>170</prism:volume>
    <prism:number>4</prism:number>
    <prism:startingPage>1267</prism:startingPage>
    <prism:endingPage>1276</prism:endingPage>
    <prism:publisher>American Society for Investigative Pathology</prism:publisher>
    <prism:category>dn</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jjray/article/1590153">
    <title>Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation.</title>
    <link>http://www.citeulike.org/user/jjray/article/1590153</link>
    <description>&lt;i&gt;Eur J Immunol, Vol. 28, No. 9. (September 1998), pp. 2760-2769.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Dendritic cells (DC) migrate into inflamed peripheral tissues where they capture antigens and, following maturation, to lymph nodes where they stimulate T cells. To gain insight into this process we compared chemokine receptor expression in immature and mature DC. Immature DC expressed CCR1, CCR2, CCR5 and CXCR1 and responded to their respective ligands, which are chemokines produced at inflammatory sites. Following stimulation with LPS or TNF-alpha maturing DC expressed high levels of CCR7 mRNA and acquired responsiveness to the CCR7 ligand EBI1 ligand chemokine (ELC), a chemokine produced in lymphoid organs. Maturation also resulted in up-regulation of CXCR4 and down-regulation of CXCR1 mRNA, while CCR1 and CCR5 mRNA were only marginally affected for up to 40 h. However, CCR1 and CCR5 were lost from the cell surface within 3 h, due to receptor down-regulation mediated by chemokines produced by maturing DC. A complete down-regulation of CCR1 and CCR5 mRNA was observed only after stimulation with CD40 ligand of DC induced to mature by LPS treatment. These different patterns of chemokine receptors are consistent with &#34;inflammatory&#34; and &#34;primary response&#34; phases of DC function.</description>
    <dc:title>Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation.</dc:title>

    <dc:creator>F Sallusto</dc:creator>
    <dc:creator>P Schaerli</dc:creator>
    <dc:creator>P Loetscher</dc:creator>
    <dc:creator>C Schaniel</dc:creator>
    <dc:creator>D Lenig</dc:creator>
    <dc:creator>CR Mackay</dc:creator>
    <dc:creator>S Qin</dc:creator>
    <dc:creator>A Lanzavecchia</dc:creator>
    <dc:source>Eur J Immunol, Vol. 28, No. 9. (September 1998), pp. 2760-2769.</dc:source>
    <dc:date>2007-08-24T15:35:36-00:00</dc:date>
    <prism:publicationYear>1998</prism:publicationYear>
    <prism:publicationName>Eur J Immunol</prism:publicationName>
    <prism:issn>0014-2980</prism:issn>
    <prism:volume>28</prism:volume>
    <prism:number>9</prism:number>
    <prism:startingPage>2760</prism:startingPage>
    <prism:endingPage>2769</prism:endingPage>
    <prism:category>ccl2</prism:category>
    <prism:category>ccr2</prism:category>
    <prism:category>dendritic_cell</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/Fritz/article/714137">
    <title>Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.</title>
    <link>http://www.citeulike.org/user/Fritz/article/714137</link>
    <description>&lt;i&gt;Eur J Pharmacol, Vol. 495, No. 2-3. (14 July 2004), pp. 97-102.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Recombinant 5-hydroxytryptamine 5-HT7 receptors are known to express constitutive, i.e., agonist-independent activity. Nonselective ligands, like methiothepin, ritanserin or clozapine behave as full inverse agonists at 5-HT7 receptors. The aim of the present study was to evaluate the degree of inverse agonist activity of three selective 5-HT7 receptor antagonists ((R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl)propyl]benzene sulfonamide or SB-258719, R-(+)-1-(toluene-3-sulfonyl)-2-[2-(4-methylpiperidin-1-yl)ethyl]-pyrrolidine or SB-258741 and (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)-pyrrolidine-1-sulfonyl)-phenol or SB-269970) in the same model. cAMP accumulation was measured in intact Chinese hamster ovary (CHO) cells expressing human recombinant 5-HT7a receptors. In these cells, 5-HT stimulated cAMP levels and a series of ligands antagonized the effect of 5-HT with a 5-HT7 receptor-like profile. SB-258719 had no inverse agonist activity, SB-258741 behaved as a partial inverse agonist and SB-269970 was a quasi-full inverse agonist (as compared to methiothepin). The inverse agonist effect of SB-269970 was antagonized in a concentration-dependent manner by SB-258719. The widespread spectrum of inverse agonist activities shown by these compounds should help assessing the physiological relevance of constitutive 5-HT7 receptor activity in native tissues.</description>
    <dc:title>Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.</dc:title>

    <dc:creator>C Mahé</dc:creator>
    <dc:creator>E Loetscher</dc:creator>
    <dc:creator>D Feuerbach</dc:creator>
    <dc:creator>W Müller</dc:creator>
    <dc:creator>MP Seiler</dc:creator>
    <dc:creator>P Schoeffter</dc:creator>
    <dc:identifier>doi:10.1016/j.ejphar.2004.05.033</dc:identifier>
    <dc:source>Eur J Pharmacol, Vol. 495, No. 2-3. (14 July 2004), pp. 97-102.</dc:source>
    <dc:date>2006-06-28T16:40:12-00:00</dc:date>
    <prism:publicationYear>2004</prism:publicationYear>
    <prism:publicationName>Eur J Pharmacol</prism:publicationName>
    <prism:issn>0014-2999</prism:issn>
    <prism:volume>495</prism:volume>
    <prism:number>2-3</prism:number>
    <prism:startingPage>97</prism:startingPage>
    <prism:endingPage>102</prism:endingPage>
    <prism:category>5-ht7</prism:category>
    <prism:category>5-ht7antagonist</prism:category>
    <prism:category>sb-258719</prism:category>
    <prism:category>sb-269970</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/rhem1224/article/705818">
    <title>Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes.</title>
    <link>http://www.citeulike.org/user/rhem1224/article/705818</link>
    <description>&lt;i&gt;J Exp Med, Vol. 192, No. 3. (7 August 2000), pp. 313-324.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;We report that stromal cell-derived factor (SDF)-1 has the remarkable capacity to induce sustained signaling through CXC chemokine receptor 4 (CXCR4). In contrast to other chemokines, such as monocyte chemotactic protein 1 (CC chemokine receptor 2 [CCR2]), macrophage inflammatory protein 1beta (CCR5), liver and activation-regulated chemokine (LARC [CCR6]), Epstein-Barr virus-induced molecule 1 ligand chemokine (ELC [CCR7]), and IP10 (CXCR3), SDF-1 stimulates the prolonged activation of protein kinase B and extracellular signal-regulated kinase (ERK)-2. Activation of protein kinase B is reversed by displacement of SDF-1 from CXCR4 or inhibition of phosphatidylinositol 3-kinase. Although increasing concentrations of SDF-1 enhance CXCR4 internalization, kinase activation is prolonged. In addition, restimulation yields &#62;60% of initial protein kinase B activity, indicating that the remaining receptors are not desensitized. Furthermore, activation is prolonged by inhibiting SDF-1 degradation. The sustained activation of cell survival and mitogenic pathways may account for the unique role of SDF-1 and CXCR4 in embryogenesis and lymphopoiesis.</description>
    <dc:title>Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes.</dc:title>

    <dc:creator>B Tilton</dc:creator>
    <dc:creator>L Ho</dc:creator>
    <dc:creator>E Oberlin</dc:creator>
    <dc:creator>P Loetscher</dc:creator>
    <dc:creator>F Baleux</dc:creator>
    <dc:creator>I Clark-Lewis</dc:creator>
    <dc:creator>M Thelen</dc:creator>
    <dc:source>J Exp Med, Vol. 192, No. 3. (7 August 2000), pp. 313-324.</dc:source>
    <dc:date>2006-06-21T14:09:51-00:00</dc:date>
    <prism:publicationYear>2000</prism:publicationYear>
    <prism:publicationName>J Exp Med</prism:publicationName>
    <prism:issn>0022-1007</prism:issn>
    <prism:volume>192</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>313</prism:startingPage>
    <prism:endingPage>324</prism:endingPage>
    <prism:category>cxcr4</prism:category>
    <prism:category>tcrmr</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/tkershaw/article/393499">
    <title>HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.</title>
    <link>http://www.citeulike.org/user/tkershaw/article/393499</link>
    <description>&lt;i&gt;J Exp Med, Vol. 186, No. 1. (7 July 1997), pp. 139-146.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Ligation of CCR5 by the CC chemokines RANTES, MIP-1alpha or MIP-1beta, and of CXCR4 by the CXC chemokine SDF-1alpha, profoundly inhibits the replication of HIV strains that use these coreceptors for entry into CD4(+) T lymphocytes. The mechanism of entry inhibition is not known. We found a rapid and extensive downregulation of CXCR4 by SDF-1alpha and of CCR5 by RANTES or the antagonist RANTES(9-68). Confocal laser scanning microscopy showed that CCR5 and CXCR4, after binding to their ligands, are internalized into vesicles that qualify as early endosomes as indicated by colocalization with transferrin receptors. Internalization was not affected by treatment with Bordetella pertussis toxin, showing that it is independent of signaling via Gi-proteins. Removal of SDF-1alpha led to rapid, but incomplete surface reexpression of CXCR4, a process that was not inhibited by cycloheximide, suggesting that the coreceptor is recycling from the internalization pool. Deletion of the COOH-terminal, cytoplasmic domain of CXCR4 did not affect HIV entry, but prevented SDF-1alpha-induced receptor downregulation and decreased the potency of SDF-1alpha as inhibitor of HIV replication. Our results indicate that the ability of the coreceptor to internalize is not required for HIV entry, but contributes to the HIV suppressive effect of CXC and CC chemokines.</description>
    <dc:title>HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.</dc:title>

    <dc:creator>A Amara</dc:creator>
    <dc:creator>SL Gall</dc:creator>
    <dc:creator>O Schwartz</dc:creator>
    <dc:creator>J Salamero</dc:creator>
    <dc:creator>M Montes</dc:creator>
    <dc:creator>P Loetscher</dc:creator>
    <dc:creator>M Baggiolini</dc:creator>
    <dc:creator>JL Virelizier</dc:creator>
    <dc:creator>F Arenzana-Seisdedos</dc:creator>
    <dc:identifier>doi:10.1084/jem.186.1.139</dc:identifier>
    <dc:source>J Exp Med, Vol. 186, No. 1. (7 July 1997), pp. 139-146.</dc:source>
    <dc:date>2005-11-15T13:16:40-00:00</dc:date>
    <prism:publicationYear>1997</prism:publicationYear>
    <prism:publicationName>J Exp Med</prism:publicationName>
    <prism:issn>0022-1007</prism:issn>
    <prism:volume>186</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>139</prism:startingPage>
    <prism:endingPage>146</prism:endingPage>
    <prism:category>cxcr4</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/tkershaw/article/393498">
    <title>The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.</title>
    <link>http://www.citeulike.org/user/tkershaw/article/393498</link>
    <description>&lt;i&gt;Nature, Vol. 382, No. 6594. (29 August 1996), pp. 833-835.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;A putative chemokine receptor that we previously cloned and termed LESTR has recently been shown to function as a co-receptor (termed fusin) for lymphocyte-tropic HIV-1 strains. Cells expressing CD4 became permissive to infection with T-cell-line-adapted HIV-1 strains of the syncytium-inducing phenotype after transfection with LESTR/fusin complementary DNA. We report here the indentification of a human chemokine of the CXC type, stromal cell-derived factor 1 (SDF-1), as the natural ligand for LESTR/fusin, and we propose the term CXCR-4 for this receptor, in keeping with the new chemokine-receptor nomenclature. SDF-1 activates Chinese hamster ovary (CHO) cells transfected with CXCR-4 cDNA as well as blood leukocytes and lymphocytes. In cell lines expressing CXCR-4 and CD4, and in blood lymphocytes, SDF-1 is a powerful inhibitor of infection by lymphocyte-tropic HIV-1 strains, whereas the CC chemokines RANTES, MIP-1 alpha and MIP-1 beta, which were shown previously to prevent infection with primary, monocyte-tropic viruses, are inactive. In combination with CC chemokines, which block the infection with monocyte/macrophage-tropic viruses, SDF-1 could help to decrease virus load and prevent the emergence of the syncytium-inducing viruses which are characteristic of the late stages of AIDS.</description>
    <dc:title>The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.</dc:title>

    <dc:creator>E Oberlin</dc:creator>
    <dc:creator>A Amara</dc:creator>
    <dc:creator>F Bachelerie</dc:creator>
    <dc:creator>C Bessia</dc:creator>
    <dc:creator>JL Virelizier</dc:creator>
    <dc:creator>F Arenzana-Seisdedos</dc:creator>
    <dc:creator>O Schwartz</dc:creator>
    <dc:creator>JM Heard</dc:creator>
    <dc:creator>I Clark-Lewis</dc:creator>
    <dc:creator>DF Legler</dc:creator>
    <dc:creator>M Loetscher</dc:creator>
    <dc:creator>M Baggiolini</dc:creator>
    <dc:creator>B Moser</dc:creator>
    <dc:source>Nature, Vol. 382, No. 6594. (29 August 1996), pp. 833-835.</dc:source>
    <dc:date>2005-11-15T13:15:35-00:00</dc:date>
    <prism:publicationYear>1996</prism:publicationYear>
    <prism:publicationName>Nature</prism:publicationName>
    <prism:issn>0028-0836</prism:issn>
    <prism:volume>382</prism:volume>
    <prism:number>6594</prism:number>
    <prism:startingPage>833</prism:startingPage>
    <prism:endingPage>835</prism:endingPage>
    <prism:category>cxcr4</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/yedmonds/article/234945">
    <title>Poly(ADP-ribose) may signal changing metabolic conditions to the chromatin of mammalian cells.</title>
    <link>http://www.citeulike.org/user/yedmonds/article/234945</link>
    <description>&lt;i&gt;Proc Natl Acad Sci U S A, Vol. 84, No. 5. (March 1987), pp. 1286-1289.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;In mammalian cells, NAD+ serves a dual role as a respiratory coenzyme and as a substrate for the posttranslational poly(ADP-ribose) modification of chromatin proteins, catalyzed by the nuclear enzyme poly(ADP-ribose) polymerase [NAD+ ADP-ribosyltransferase, EC 2.4.2.30]. Biological evidence strongly suggests that poly(ADP-ribosyl)ation modulates chromatin functions, although the precise molecular mechanisms involved have not yet been elucidated. Here we describe conditions for the rapid uptake of exogenously supplied NAD+ by living hepatocytes in primary monolayer culture. Raising the intracellular NAD+ concentration by 70% caused a 5-fold increase of chromatin-bound poly(ADP-ribose). We conclude that the constitutive level of posttranslational poly(ADP-ribose) modifications of chromatin proteins in mammalian cells is related to the availability of NAD+, which varies in different physiological and pathological states. We propose that poly-(ADP-ribose) may serve a hitherto unrecognized function by signaling altered metabolic conditions to the chromatin and thus modulate its functions in tune with changing metabolic states.</description>
    <dc:title>Poly(ADP-ribose) may signal changing metabolic conditions to the chromatin of mammalian cells.</dc:title>

    <dc:creator>P Loetscher</dc:creator>
    <dc:creator>R Alvarez-Gonzalez</dc:creator>
    <dc:creator>FR Althaus</dc:creator>
    <dc:source>Proc Natl Acad Sci U S A, Vol. 84, No. 5. (March 1987), pp. 1286-1289.</dc:source>
    <dc:date>2005-06-22T19:23:42-00:00</dc:date>
    <prism:publicationYear>1987</prism:publicationYear>
    <prism:publicationName>Proc Natl Acad Sci U S A</prism:publicationName>
    <prism:issn>0027-8424</prism:issn>
    <prism:volume>84</prism:volume>
    <prism:number>5</prism:number>
    <prism:startingPage>1286</prism:startingPage>
    <prism:endingPage>1289</prism:endingPage>
    <prism:category>chromatin</prism:category>
    <prism:category>par</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/yedmonds/article/234925">
    <title>A new highly selective physicochemical assay to measure NAD+ in intact cells.</title>
    <link>http://www.citeulike.org/user/yedmonds/article/234925</link>
    <description>&lt;i&gt;Anal Biochem, Vol. 156, No. 2. (1 August 1986), pp. 473-480.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;A simple, fast, and highly specific chromatographic method for measuring the content of NAD+ in intact cells has been developed. This procedure involves the separation of NAD+ from the bulk of acid-soluble nucleosides, nucleotides, and other pyridine containing molecules by affinity chromatography on dihydroxyboronyl-Bio-Rex. The boronate purified preparations were utilized for the quantification of NAD+ by strong anion exchange high-pressure liquid chromatography under isocratic conditions using a low salt buffer system. The overall recovery of the method exceeded 80%. This new method was applied to determine the extent of NAD+ consumption in intact hepatocytes following treatment with two different DNA damaging agents. A major advantage of this method is that it allows for the simultaneous determination of poly(ADP-ribose) in the acid-insoluble fraction of the same sample.</description>
    <dc:title>A new highly selective physicochemical assay to measure NAD+ in intact cells.</dc:title>

    <dc:creator>R Alvarez-Gonzalez</dc:creator>
    <dc:creator>R Eichenberger</dc:creator>
    <dc:creator>P Loetscher</dc:creator>
    <dc:creator>FR Althaus</dc:creator>
    <dc:source>Anal Biochem, Vol. 156, No. 2. (1 August 1986), pp. 473-480.</dc:source>
    <dc:date>2005-06-22T17:09:42-00:00</dc:date>
    <prism:publicationYear>1986</prism:publicationYear>
    <prism:publicationName>Anal Biochem</prism:publicationName>
    <prism:issn>0003-2697</prism:issn>
    <prism:volume>156</prism:volume>
    <prism:number>2</prism:number>
    <prism:startingPage>473</prism:startingPage>
    <prism:endingPage>480</prism:endingPage>
    <prism:category>methods</prism:category>
    <prism:category>nadnadh</prism:category>
</item>



</rdf:RDF>

